PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, today announced results from a Phase 2 study of LYT-100-COV (deupirfenidone) in .
DUBLIN (BUSINESS WIRE) The "Africa Private LTE and 5G Network Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027" report has been added to ResearchAndMarkets.com's offering. The country research report on Africa private LTE and 5G network market is a customer intelligence and competitive study of the Africa market. Moreover,…